Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.3
-2.96 %
$ 334 M
Market Cap
-4.37
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
SNDL Inc.
| Revenue | 920 M |
| Cost Of Revenue | 680 M |
| Gross Profit | 240 M |
| Operating Expenses | 344 M |
| Operating Income | -104 M |
| Other Expenses | -7.61 M |
| Net Income | -96.2 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Feb-2018 | Feb-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 920.4 | 909.0 | 712.2 | 56.1 | 60.9 | 75.9 | 9.7 | 0 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 680.1 | 718.6 | 571.8 | 63.1 | 110.8 | 36.1 | 9.3 | 0 |
| Gross Profit | 240.3 | 190.4 | 140.4 | (7.0) | (49.9) | 39.8 | 0.4 | 0 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 344.1 | 353.2 | 201.6 | 60.7 | 47.4 | 99.3 | 11.1 | 1.5 |
| Selling, General and Administrative Expenses | 219.3 | 230.2 | 158.3 | 55.7 | 46.3 | 92.9 | 9.0 | 1.4 |
| Research and Development Expenses | 0.3 | 0.3 | 2.4 | 2.4 | 0.5 | 2.4 | 0.4 | 0 |
| Operating Income | (103.8) | (163.2) | (61.3) | (132.1) | (185.4) | (59.6) | (12.9) | (1.5) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 7.7 | 7.9 | 5.9 | 0.8 | 9.1 | 21.2 | 0 | 0 |
| Total Other Income | (1.8) | (8.8) | (32.0) | (100.3) | (20.9) | (93.9) | (0.1) | 16.6 K |
| Pre-Tax Income | (105.6) | (172.0) | (379.8) | (232.5) | (206.3) | (276.3) | (13.0) | (1.5) |
| NET INCOME | ||||||||
| Tax Provision | (9.4) | 0 | (7.3) | (2.3) | 49.6 | (4.6) | 4.5 | 12.1 K |
| Net Income | (94.8) | (172.7) | (372.4) | (230.2) | (255.9) | (271.6) | (13.0) | (1.5) |
| EPS | 0.36 | 0.67 | 1.62 | 1.24 | 11.7 | 31.7 | 1.55 | 0.18 |